About Exicure
Exicure is a company based in Skokie (United States) founded in 2009.. Exicure has raised $72.29 million across 12 funding rounds from investors including AbbVie, Illumina and Aon. The company has 7 employees as of December 31, 2024. Exicure offers products and services including SNA Platform. Exicure operates in a competitive market with competitors including Biogen, Denali Therapeutics, ADMA Biologics, Kymeratx and Poseida Therapeutics, among others.
- Headquarter Skokie, United States
- Employees 7 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Exicure, Inc.
-
Annual Revenue
$500 K0as on Dec 31, 2024
-
Net Profit
$-9.7 M42.65as on Dec 31, 2024
-
EBITDA
$-4.13 M67.52as on Dec 31, 2024
-
Total Equity Funding
$72.29 M (USD)
in 12 rounds
-
Latest Funding Round
$1.3 M (USD), Post-IPO
Nov 01, 2024
-
Investors
AbbVie
& 15 more
-
Employee Count
7
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Exicure
Exicure is a publicly listed company on the NASDAQ with ticker symbol XCUR in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Exicure
Exicure offers a comprehensive portfolio of products and services, including SNA Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for creating nucleic acid therapies targeting diseases
Funding Insights of Exicure
Exicure has successfully raised a total of $72.29M across 12 strategic funding rounds. The most recent funding activity was a Post-IPO round of $1.3 million completed in November 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 12
- Last Round Post-IPO — $1.3M
-
First Round
First Round
(01 Dec 2009)
- Investors Count 16
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2024 | Amount | Post-IPO - Exicure | Valuation |
investors |
|
| Feb, 2023 | Amount | Post-IPO - Exicure | Valuation |
investors |
|
| Sep, 2022 | Amount | Post-IPO - Exicure | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Exicure
Exicure has secured backing from 16 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include AbbVie, Illumina and Aon. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early stage venture capital firm investing in US
|
Founded Year | Domain | Location | |
|
Venture capital investing and portfolio management services for accredited investors.
|
Founded Year | Domain | Location | |
|
Climate solutions are advanced via venture capital and startup acceleration.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Exicure
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Exicure
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Exicure Comparisons
Competitors of Exicure
Exicure operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biogen, Denali Therapeutics, ADMA Biologics, Kymeratx and Poseida Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| domain | founded_year | HQ Location |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| domain | founded_year | HQ Location |
Plasma-based biologics are developed for immune deficiency and infectious diseases.
|
|
| domain | founded_year | HQ Location |
Small molecule protein degraders are developed for various disorders.
|
|
| domain | founded_year | HQ Location |
Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies
|
|
| domain | founded_year | HQ Location |
Precision diagnostic and prognostic tests are developed by Castle Biosciences.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Exicure
Frequently Asked Questions about Exicure
When was Exicure founded?
Exicure was founded in 2009.
Where is Exicure located?
Exicure is headquartered in Skokie, United States. It is registered at Skokie, Illinois, United States.
Is Exicure a funded company?
Exicure is a funded company, having raised a total of $72.29M across 12 funding rounds to date.
How many employees does Exicure have?
As of Dec 31, 2024, the latest employee count at Exicure is 7.
What is the annual revenue of Exicure?
Annual revenue of Exicure is $500K as on Dec 31, 2024.
What does Exicure do?
Exicure was founded in 2009 in Skokie, United States, within the biotechnology sector. A platform based on spherical nucleic acid (SNA) technology is employed to create immunomodulatory and gene silencing drugs targeting validated pathways. A pipeline of candidates is advanced for applications in oncology, such as solid tumors, and immunology, including psoriasis and inflammatory disorders. Operations focus on therapeutic development for these disease areas.
Who are the top competitors of Exicure?
Exicure's top competitors include ADMA Biologics, Juno Therapeutics and BioNTech.
What products or services does Exicure offer?
Exicure offers SNA Platform.
Is Exicure publicly traded?
Yes, Exicure is publicly traded on NASDAQ under the ticker symbol XCUR.
Who are Exicure's investors?
Exicure has 16 investors. Key investors include AbbVie, Illumina, Aon, Groupon, and Luye Pharma.
What is Exicure's ticker symbol?
The ticker symbol of Exicure is XCUR on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.